Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer
Geburtshilfe und Frauenheilkunde · 01.05.2025 · 85 (05) · 507-519
DOI: 10.1055/a-2515-2366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.05.2025. Verfasst von Diana Lüftner und 30 weiteren Autor:innen. Beteiligte Einrichtung: Immanuel Hospital Märkische Schweiz, Buckow, Germany & Medical University of Brandenburg Theodor-Fontane, Rüdersdorf, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The use of CDK4/6 inhibitors, the new PI3K/AKT-kinase inhibitors, selective estrogen receptor-degraders (SERDs), antibody-drug conjugates, immune therapies and PARP inhibitors in recent years has resulted in a marked change in the therapy landscape for patients with advanced stage breast cancer. CDK4/6 inhibitors, trastuzumab deruxtecan, and sacituzumab govitecan have all been shown to provide significant overall survival benefits compared to conventional chemotherapy. Other substances are also showing promising results and hold out the hope that further analysis of the overall survival benefits will be available in the near future. The speed at which studies are now being carried out has markedly increased, and conferences and specialist journals are now constant sources of new information. This review summarizes the most recent publications and conference presentations on the treatment of patients with advanced stage breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immanuel Hospital Märkische Schweiz, Buckow, Germany & Medical University of Brandenburg Theodor-Fontane, Rüdersdorf, Germany.
- Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.
- Department of Gynecology and Obstetrics, Tübingen University Hospital, Tübingen, Germany.
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
- Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Düsseldorf, Germany.
- Onkologie Aschaffenburg, Aschaffenburg, Germany.
Zitieren
APA
Lüftner, D., Kolberg, H. C., Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Jackisch, C., Marme, F., Keller, K., Hörner, M., Goossens, C., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Radosa, J. C., …, & Lux, M. P. (2025). Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 85(05), 507-519. https://doi.org/10.1055/a-2515-2366
Vancouver
Lüftner D, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, et al. Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer. Geburtshilfe und Frauenheilkunde. 2025;85(05):507-519. doi:10.1055/a-2515-2366
BibTeX
@article{Lftner2025,
author = {Lüftner, Diana and Kolberg, Hans-Christian and Hartkopf, Andreas D and Fehm, Tanja N and Welslau, Manfred and Müller, Volkmar and Schütz, Florian and Fasching, Peter A and Jackisch, Christian and Marme, Frederik and Keller, Katharina and Hörner, Manuel and Goossens, Chloë and Belleville, Erik and Untch, Michael and Thill, Marc and Tesch, Hans and Ditsch, Nina and Radosa, Julia C and Banys-Paluchowski, Maggie and Wöckel, Achim and Harbeck, Nadia and Stickeler, Elmar and Bartsch, Rupert and Aktas, Bahriye and Schneeweiss, Andreas and Ettl, Johannes and Taran, Florin-Andrei and Janni, Wolfgang and Würstlein, Rachel and Lux, Michael P},
title = {Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2025},
volume = {85},
number = {05},
pages = {507--519},
doi = {10.1055/a-2515-2366}
}
EUVIMED